Year: 2020

WAKIX®(pitolisant) Total Revenue of $45.6 Million for Third Quarter of 2020Differentiated Product Profile Aligns with Unmet Medical NeedOn Track to Initiate Phase 2 Trial in Patients with Prader-Willi Syndrome by Year EndConference Call and Webcast to be held today at 8:30 a.m. Eastern TimePLYMOUTH MEETING, Penn. and CHICAGO, Nov. 12, 2020 (GLOBE NEWSWIRE) — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today reported financial results for the quarter ended September 30, 2020, and provided recent business updates.“Harmony experienced another productive quarter with continued WAKIX revenue growth and meaningful advancement of our key clinical...

EL DORADO, Ark., Nov. 12, 2020 (GLOBE NEWSWIRE) — Murphy USA Inc. (NYSE: MUSA) will be participating virtually at the Stephens Annual Investment Conference on Wednesday, November 18th, 2020 at 3:00 PM ET. The webcast can be accessed through the Investor Relations section of Murphy USA’s website at http://ir.corporate.murphyusa.com.About Murphy USAMurphy USA (NYSE:MUSA) is a leading retailer of gasoline and convenience merchandise with nearly 1,500 sites located primarily in the Southwest, Southeast and Midwest United States. The company and its team of nearly 10,000 employees serve an estimated 1.7 million customers each day through its network of retail gasoline stations in 25 states. The majority of Murphy USA’s sites are located in close proximity to Walmart stores. The company also markets gasoline and other products at...

Stock Exchange AnnouncementCopenhagen, 12 November 2020The Board of Directors has today approved the interim report for the period 1 January – 30 September 2020.Summary of first nine months of 2020Some 6.7 million passengers passed through the terminals at Copenhagen Airports (CPH) in the first nine months of 2020, a decline of 71.3% from the year-earlier period. CPH continues to be hard hit by the knock-on effects of the coronavirus pandemic that took hold in March and locked down most of the world. Travel activity began to pick up over the summer period, but as the COVID-19 flared up again and travel restrictions were significantly tightened, the recovery in travel demand evaporated. In an effort to mitigate the decline in passenger revenue, CPH has taken measures to cut both investments and operating costs and in late August unfortunately...

SelskabsmeddelelseKøbenhavn, den 12. november 2020 

Fireside chat with live audio webcast on Thursday, November 19th at 12:35 PM ESTNorwood, MA, Nov. 12, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 12:35 PM EST.A live audio webcast of the presentation will be accessible on the Events page of the Investors section of the Corbus website, www.corbuspharma.com. The webcast replay will be available approximately two hours after the event and will be archived for 90 days.About Corbus Corbus Pharmaceuticals Holdings,...

Ellen utvidgar samarbetet med sin distributör Bio-Tech som i dagsläget ansvarar för försäljning och marknadsföring av Ellens produktportfölj i Ungern. Under hösten börjar Ellen att sälja sina probiotiska produkter på apotek i Portugal och Malta.Ett av Ellens prioriterade områden framåt är bland annat att utveckla samarbetet med befintliga distributörer för att fortsätta skapa nya affärsmöjligheter på sikt och på sätt driva tillväxt.Ellen har ett långtgående samarbete med Bio-Tech sedan 2009. Bio-Tech verkar på cirka 30 marknader med stort fokus i Europa. De ha god kännedom om de marknader de befinner sig på och har etablerade kontakter både inom apotekskanalerna och gentemot flera stora retailkedjor.  Ellen kommer i och med det utökade samarbetet med Bio-Tech att implementera sitt sortiment i apotek i Portugal och Malta. Redan nu i november...

WALL, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and other multi-factor identity and access management (IAM) solutions for strong, convenient user authentication and large-scale identity applications, today reported results for its third quarter ended September 30, 2020 (Q3’20). BIO-key will host a conference call today at 10:00 a.m. ET (details below) to review its results and outlook.Recent News and Highlights:BIO-key ended Q3’20 with $18.4M of cash reflecting the completion of a $24.8 million underwritten public offering of stock and warrants in July.Q3’20 revenue of $943K or more than double Q3’19 revenue of $453K. BIO-key’s Q3’20 results benefitted from the acquisition of PortalGuard® developer PistolStar. PortalGuard is an enterprise multifactor authentication...

Selskabsmeddelelse nr. 10 – 2020København, den 12. november 2020Delårsrapport for 3. kvartal 2020Omsætningen i perioden 1. januar 2020 – 30. september 2020 udgør DKK 58,5 mio. (DKK 65,1 mio. i samme periode i 2019) Koncernens resultat af fortsættende aktiviteter før skat udviser et overskud på DKK 5,1 mio. (DKK 6,7 mio. i samme periode i 2019), hvilket er i overensstemmelse med de senest udmeldte resultatforventninger, men lavere end forventet ved regnskabsårets start. Egenkapitalen udgør DKK 128,8 mio., svarende til en indre værdi pr. aktie på DKK 52,1. NTR Holding koncernen forventer for 2020 uændret en omsætning i niveauet DKK 70-80 mio. og et resultat af fortsættende aktiviteter før skat i niveauet DKK 5 mio. For yderligere information kontakt:Ole Mikkelsen, direktør, e-mail: om@ntr.dk, mobil: +45 30 66 96 30Vedhæftet filNTR Q3 2...

ENDEAVOUR REPORTS STRONG Q3-2020 RESULTS AND DECLARES FIRST DIVIDENDRecord cash flow per share l Net debt reduced by $298m to $175m l First dividend declared at attractive yieldHIGHLIGHTS Q3-2020 production increased by 64% over Q2-2020 to 244koz while AISC decreased by $33/oz to $906/ozProduction expected to continue to increase in Q4-2020 due to Boungou restart and ramp-up of Kari Pump at HoundéOn track to achieve full year pro forma production guidance of 995—1,095koz at an AISC of $865—$915/ozRecord Operating Cash Flow before working capital of $223m or $1.37/share for Q3-2020; $427m or $3.33/share for YTD-2020Adjusted Net Earnings of $72m or $0.44/share in Q3-2020; $159m or $1.24/share for YTD-2020Significant deleveraging during Q3-2020 as Net Debt decreased by $298m to $175mHealthy leverage ratio as Net Debt / Adjusted EBITDA stands...

Seattle, WA, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — ReelTime VR/ReelTime Media (OTC:RLTR) has received notification from NASDAQ’s symbol reservation department stating, “Your request to reserve the ticker symbol ‘RT’, for ReelTime Rentals, Inc. has been approved and will be reserved for you for twenty four months from the date of the reservation 11 March 2022. Nasdaq is committed to supporting our global network of companies throughout all their life stages – before, during and after the Listing.”Two-letter symbols such as “RT” are exceedingly rare and coveted, having only 325 possible combinations and even fewer that trade on NASDAQ, as the remaining two-letter symbols are spread across other trading platforms. The particular symbol “RT” as an example became...